Production of Human CRISPR-Engineered CAR-T Cells

Sangya Agarwal(Amgen (United States)), Carl H. June(University of Pennsylvania), Bruce L. Levine(University of Pennsylvania), Nils Wellhausen(University of Pennsylvania)
Journal of Visualized Experiments
March 15, 2021
10.3791/62299-v
Cited by 2

Related Papers

CAR T Cells Produced in vivo to Treat Cardiac Injury
|HAL (Le Centre pour la Communication Scientifique Directe)|2023|940
Targeting cardiac fibrosis with engineered T cells
|Nature|2019|799
Enhancing CAR T cell persistence through ICOS and 4-1BB costimulation
|JCI Insight|2018|573
An NK-like CAR T cell transition in CAR T cell dysfunction
|Cell|2021|398
Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T Cells
|Cancer Immunology Research|2015|332